What is Royalty Pharma's loans and lending commitments?

Royalty Pharma (RPRX) reported loans and lending commitments of $17.32B in Q1 2026.

How has Royalty Pharma's loans and lending commitments changed year-over-year?

Royalty Pharma's loans and lending commitments increased by 10.0% year-over-year, from $15.75B to $17.32B.

What is the long-term trend for Royalty Pharma's loans and lending commitments?

Over 5 years (2020 to 2025), Royalty Pharma's loans and lending commitments has grown at a 5.7% compound annual growth rate (CAGR), from $12.96B to $17.06B.

Discontinued — last reported Q3 '17

Current Assets

Loans and Lending Commitments

Royalty Pharma Loans and Lending Commitments increased by 1.5% to $17.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.0%, from $15.75B to $17.32B. Over 5 years (FY 2020 to FY 2025), Loans and Lending Commitments shows an upward trend with a 5.7% CAGR.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

First reportedQ4 2016

Last reportedQ3 2017

Metric ID: loans_and_lending_commitments

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$13.53B	$14.59B	$14.33B	$14.04B	$14.06B	$14.96B	$14.18B	$14.27B	$14.00B	$13.97B	$14.83B	$14.13B	$14.64B	$15.73B	$15.91B	$15.75B	$15.98B	$16.62B	$17.06B	$17.32B
QoQ Change	—	+7.9%	-1.8%	-2.1%	+0.2%	+6.4%	-5.2%	+0.6%	-1.9%	-0.2%	+6.1%	-4.7%	+3.6%	+7.5%	+1.1%	-1.0%	+1.5%	+4.0%	+2.6%	+1.5%
YoY Change	—	—	—	—	+3.9%	+2.5%	-1.0%	+1.7%	-0.5%	-6.6%	+4.5%	-1.0%	+4.6%	+12.6%	+7.3%	+11.5%	+9.1%	+5.7%	+7.2%	+10.0%

Range$13.53B – $17.32B

CAGR+5.3%

Avg YoY Growth+4.5%

Median YoY Growth+4.6%

Current Streak4 quarters growth

Frequently Asked Questions

What is Royalty Pharma's loans and lending commitments?: Royalty Pharma (RPRX) reported loans and lending commitments of $17.32B in Q1 2026.
How has Royalty Pharma's loans and lending commitments changed year-over-year?: Royalty Pharma's loans and lending commitments increased by 10.0% year-over-year, from $15.75B to $17.32B.
What is the long-term trend for Royalty Pharma's loans and lending commitments?: Over 5 years (2020 to 2025), Royalty Pharma's loans and lending commitments has grown at a 5.7% compound annual growth rate (CAGR), from $12.96B to $17.06B.